Type
. Reduction of host cell mitochondrial activity as Mycobacterium leprae's strategy to evade host innate immunity. Immunological reviews. 2021;.
Type
. A Clinicohistopathological Correlation of Hansen's Disease in a Rural Tertiary Care Hospital of Central India. Journal of global infectious diseases [Internet]. 2020;12(4):191-196. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045542/
Type
. Reverse vaccinology and subtractive genomics approaches for identifying common therapeutics against Mycobacterium leprae and Mycobacterium lepromatosis. The journal of venomous animals and toxins including tropical diseases [Internet]. 2021;27:e20200027. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040911/pdf/1678-9199-jvatitd-27-e20200027.pdf
Type
. Comparing socio-economic conditions of mother and children with leprosy in endemic and non-endemic areas in east Java, Indonesia. African journal of infectious diseases [Internet]. 2021;15(2):52-58. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052967/pdf/AJID-15-52.pdf
Type
. Reviewing the therapeutic management of leprosy in primary care: demand case series referred to a University Hospital in the Midwest region of Brazil. Anais brasileiros de dermatologia [Internet]. 2021;. Available from: https://www.sciencedirect.com/science/article/pii/S0365059621000519?via%3Dihub
Type
. Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis. BMC infectious diseases [Internet]. 2021;21(1):347. Available from: https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-021-06041-7.pdf
Type
. Leprosy Screening Based on Artificial Intelligence: Development of a Cross-Platform App. JMIR mHealth and uHealth [Internet]. 2021;9(4):e23718. Available from: https://mhealth.jmir.org/2021/4/e23718
Type
. Presence of Senescent and Memory CD8+ Leukocytes as Immunocenescence Markers in Skin Lesions of Elderly Leprosy Patients. Frontiers in immunology [Internet]. 2021;12:647385. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991105/pdf/fimmu-12-647385.pdf
Type
. Improving treatment outcomes for leprosy in Pernambuco, Brazil: a qualitative study exploring the experiences and perceptions of retreatment patients and their carers. BMC infectious diseases [Internet]. 2021;21(1):282. Available from: https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-021-05980-5.pdf
Type
. Physical disabilities caused by leprosy in 100 million cohort in Brazil. BMC infectious diseases [Internet]. 2021;21(1):290. Available from: https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-021-05846-w.pdf